<DOC>
	<DOCNO>NCT00883870</DOCNO>
	<brief_summary>This clinical trial aim study safety efficacy adult mesenchymal stem cell critical limb ischemia .</brief_summary>
	<brief_title>Mesenchymal Stem Cells Critical Limb Ischemia</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Plasma-lyte 148</mesh_term>
	<criteria>Males female nonchild bear potential age group 1860 yr Indian origin . Established CLI , clinically hemodynamically confirm per Rutherford II4 , III5 , III6 ; Patients Infrainguinal arterial occlusive disease rest pain ischemic ulcer/necrosis , eligible fail traditional revascularization treatment ( No option patient ) Ankle Brachial Pressure Index ( ABPI ) ≤ 0.6 ankle pressure ≤ 70 mm Hg TcPO2 ≤ 60 mmHg foot Patients associate Type II Diabetes , medication well control ( HbA1c ≤ 8 % ) without complication Patients able understand requirement study , willing provide voluntary write informed consent , abide study requirement , agree return require followup visit Normal liver renal function On regular medication hypertension Patients CLI suitable surgical percutaneous revascularization determine surgeon perform vascular procedure patient acute/chronic inflammatory condition CLI patient require amputation proximal transmetatarsal level Patients gait disturbance reason CLI . Type I diabetes Patients respiratory complications/left ventricular ejection fraction &lt; 25 % f ) Stroke myocardial infarction within last 3 month Patients contraindicate MRA Have clinically serious and/or unstable intercurrent infection , medical illness condition uncontrolled whose control , opinion Investigator , may jeopardize participation study complication therapy Documented terminal illness cancer concomitant disease process life expectancy le 1 year Patients already enrol another investigational drug trial complete within 3 month . History severe alcohol drug abuse within 3 month screen . Hb % &lt; 10 gm % , Serum Creatinine ≥ 2mg % , Serum Total Bilirubin ≥2mg % , HbA1c &gt; 8 % Women child bear potential , pregnant lactate woman . Patients test positive HIV 1 , HCV , HBV ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>mesenchymal stem cell</keyword>
	<keyword>critical limb ischemia</keyword>
</DOC>